72B702FDd01 - •Describe the particular gelfree proteomics...

Info iconThis preview shows page 1. Sign up to view the full content.

View Full Document Right Arrow Icon
Visit Pronota – some things to reconsider •Discuss the powefull potency of biomarkers for monitoring the course of cancer and gauging the efficacy and safety of novel therapeutic agents •Describe the challenge of cancer biomarker identification in body fluids • at the level of sampling • complexity of samples
Background image of page 1
This is the end of the preview. Sign up to access the rest of the document.

Unformatted text preview: •Describe the particular gelfree proteomics approch of Pronota to find novel biomarkers and what were the major improvements to reach high sensitivity detection. •Discuss proteomic versus DNA approach to stratify cancer patients towards clinical outcome and therapy...
View Full Document

Ask a homework question - tutors are online